CompletedNot Applicable

Protective Antibody Level After COVID-19 Vaccination Among Patients Under Hemodialysis

South Korea31 participantsStarted 2021-04-20

Plain-language summary

The aim of the study is to evaluate the level of neutralizing antibody against SARS-CoV-2 after COVID-19 vaccination in patients under hemodialysis. To this end, the level of neutralizing antibody of patients under hemodialysis is compared to that of healthy population.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The person who is vaccinated with ChAdOx1 (COVID-19 vaccine) * The person who agrees with the protocol of the study Exclusion Criteria: * Age \< 18 years * Pregnants * Experience of COVID-19 infection

What they're measuring

The change in the level of neutralizing antibody against SARS-CoV-2

Timeframe: Day 0, 14, 28, 56, 91, 120

Trial details

NCT IDNCT04871945

SponsorHanyang University Seoul Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-09-30

View on ClinicalTrials.gov More Covid19 trials